Industry Growth Insights published a new data on “RNA Analysis /Transcriptomic Market”. The research report is titled “RNA Analysis /Transcriptomic Market research by Types (Microarrays, Sequencing, Polymerase Chain Reaction, RNA Interference), By Applications (Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics), By Players/Companies Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, GenXPro GmbH, CD Genomics, Promega Corporation, Cenix BioScience GmbH, Takara Holdings, Inc., bioMérieux SA, LC Sciences LLC”.
Scope Of The Report
Report Attributes
Report Details
Report Title
RNA Analysis /Transcriptomic Market Research Report
By Type
Microarrays, Sequencing, Polymerase Chain Reaction, RNA Interference
By Application
Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics
By Companies
Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, GenXPro GmbH, CD Genomics, Promega Corporation, Cenix BioScience GmbH, Takara Holdings, Inc., bioMérieux SA, LC Sciences LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global RNA Analysis /Transcriptomic Market Report Segments:
The global RNA Analysis /Transcriptomic market is segmented on the basis of:
Types
Microarrays, Sequencing, Polymerase Chain Reaction, RNA Interference
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Fluidigm Corporation
- Eurofins Scientific
- Sequentia Biotech SL
- Acobiom
- GenXPro GmbH
- CD Genomics
- Promega Corporation
- Cenix BioScience GmbH
- Takara Holdings, Inc.
- bioMérieux SA
- LC Sciences LLC
Highlights of The RNA Analysis /Transcriptomic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microarrays
- Sequencing
- Polymerase Chain Reaction
- RNA Interference
- By Application:
- Clinical Diagnostics
- Drug Discovery
- Toxicogenomics
- Comparative Transcriptomics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the RNA Analysis /Transcriptomic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
RNA analysis is the process of extracting and analyzing the genetic information found in RNA molecules. Transcriptomic analysis refers to the study of all transcripts, or copies of genes, in a given sample. This information can be used to identify differentially expressed genes and pathways, as well as characterize gene expression patterns across different tissues or cell types.
Some of the major players in the rna analysis /transcriptomic market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, GenXPro GmbH, CD Genomics, Promega Corporation, Cenix BioScience GmbH, Takara Holdings, Inc., bioM©rieux SA, LC Sciences LLC.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 RNA Analysis /Transcriptomic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 RNA Analysis /Transcriptomic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 RNA Analysis /Transcriptomic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the RNA Analysis /Transcriptomic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global RNA Analysis /Transcriptomic Market Size & Forecast, 2018-2028
4.5.1 RNA Analysis /Transcriptomic Market Size and Y-o-Y Growth
4.5.2 RNA Analysis /Transcriptomic Market Absolute $ Opportunity
Chapter 5 Global RNA Analysis /Transcriptomic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 RNA Analysis /Transcriptomic Market Size Forecast by Type
5.2.1 Microarrays
5.2.2 Sequencing
5.2.3 Polymerase Chain Reaction
5.2.4 RNA Interference
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global RNA Analysis /Transcriptomic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 RNA Analysis /Transcriptomic Market Size Forecast by Applications
6.2.1 Clinical Diagnostics
6.2.2 Drug Discovery
6.2.3 Toxicogenomics
6.2.4 Comparative Transcriptomics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global RNA Analysis /Transcriptomic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 RNA Analysis /Transcriptomic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America RNA Analysis /Transcriptomic Analysis and Forecast
9.1 Introduction
9.2 North America RNA Analysis /Transcriptomic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America RNA Analysis /Transcriptomic Market Size Forecast by Type
9.6.1 Microarrays
9.6.2 Sequencing
9.6.3 Polymerase Chain Reaction
9.6.4 RNA Interference
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America RNA Analysis /Transcriptomic Market Size Forecast by Applications
9.10.1 Clinical Diagnostics
9.10.2 Drug Discovery
9.10.3 Toxicogenomics
9.10.4 Comparative Transcriptomics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe RNA Analysis /Transcriptomic Analysis and Forecast
10.1 Introduction
10.2 Europe RNA Analysis /Transcriptomic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe RNA Analysis /Transcriptomic Market Size Forecast by Type
10.6.1 Microarrays
10.6.2 Sequencing
10.6.3 Polymerase Chain Reaction
10.6.4 RNA Interference
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe RNA Analysis /Transcriptomic Market Size Forecast by Applications
10.10.1 Clinical Diagnostics
10.10.2 Drug Discovery
10.10.3 Toxicogenomics
10.10.4 Comparative Transcriptomics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific RNA Analysis /Transcriptomic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific RNA Analysis /Transcriptomic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific RNA Analysis /Transcriptomic Market Size Forecast by Type
11.6.1 Microarrays
11.6.2 Sequencing
11.6.3 Polymerase Chain Reaction
11.6.4 RNA Interference
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific RNA Analysis /Transcriptomic Market Size Forecast by Applications
11.10.1 Clinical Diagnostics
11.10.2 Drug Discovery
11.10.3 Toxicogenomics
11.10.4 Comparative Transcriptomics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America RNA Analysis /Transcriptomic Analysis and Forecast
12.1 Introduction
12.2 Latin America RNA Analysis /Transcriptomic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America RNA Analysis /Transcriptomic Market Size Forecast by Type
12.6.1 Microarrays
12.6.2 Sequencing
12.6.3 Polymerase Chain Reaction
12.6.4 RNA Interference
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America RNA Analysis /Transcriptomic Market Size Forecast by Applications
12.10.1 Clinical Diagnostics
12.10.2 Drug Discovery
12.10.3 Toxicogenomics
12.10.4 Comparative Transcriptomics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) RNA Analysis /Transcriptomic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) RNA Analysis /Transcriptomic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) RNA Analysis /Transcriptomic Market Size Forecast by Type
13.6.1 Microarrays
13.6.2 Sequencing
13.6.3 Polymerase Chain Reaction
13.6.4 RNA Interference
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) RNA Analysis /Transcriptomic Market Size Forecast by Applications
13.10.1 Clinical Diagnostics
13.10.2 Drug Discovery
13.10.3 Toxicogenomics
13.10.4 Comparative Transcriptomics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 RNA Analysis /Transcriptomic Market: Competitive Dashboard
14.2 Global RNA Analysis /Transcriptomic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific, Inc.
14.3.2 Bio-Rad Laboratories, Inc.
14.3.3 Merck KGaA
14.3.4 Agilent Technologies, Inc.
14.3.5 F. Hoffmann-La Roche Ltd.
14.3.6 Danaher Corporation
14.3.7 Fluidigm Corporation
14.3.8 Eurofins Scientific
14.3.9 Sequentia Biotech SL
14.3.10 Acobiom
14.3.11 GenXPro GmbH
14.3.12 CD Genomics
14.3.13 Promega Corporation
14.3.14 Cenix BioScience GmbH
14.3.15 Takara Holdings, Inc.
14.3.16 bioMérieux SA
14.3.17 LC Sciences LLC
